AtaiBeckley Inc.
CIK:
0002081043
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
C/O ATAI LIFE SCIENCES US, INC., NEW YORK, NY, 10119
Mailing Address
C/O ATAI LIFE SCIENCES US, INC., NEW YORK, NY, 10119
Phone
1 929 207 2670
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025 FY
$4.09M
Revenue
-$149.27M
Net Income
$292.72M
Total Assets
$70.72M
Total Liabilities
$221.87M
Stockholders' Equity
$85.30M
Cash & Equivalents
$-0.93
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 24, 2026 | View on SEC |
| 3 Initial insider ownership report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 10-K Annual financial report | March 6, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 8-K Current report of material events | February 26, 2026 | View on SEC |
| 8-K Current report of material events | February 19, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 17, 2026 | View on SEC |
Annual Reports
10-K
March 6, 2026
- AB-101, the lead compound for treatment-resistant depression, successfully completed a Phase 2b clinical trial with statistically significant improvements and a favorable safety profile.
- A strong cash position of $285.6 million as of December 31, 2024, provides an estimated cash runway into late 2026, funding ongoing clinical trials.
Insider Trading
SELL
2 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.